Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Mineur

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Annals of Hematology|February 15, 2011
Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromesMichel Delforge, Dominik Selleslag, Agnès Triffet, et al.
Haematologica|June 10, 2017
Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modificationsEmerence Crompot, Michael Van Damme, Karlien Pieters, et al.
Plos One|May 16, 2015
Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative controlEmerence Crompot, Michael Van Damme, Hugues Duvillier, et al.
European Journal of Haematology|December 30, 2017
Disease and treatment characteristics of polycythemia vera patients in Belgium: Results from a scientific surveyTimothy Devos, Yves Beguin, Lucien Noens, et al.
Haematologica|November 8, 2011
AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatmentsBasile Stamatopoulos, Nathalie Meuleman, Cécile De Bruyn, et al.
Blood|April 8, 2009
Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO studyLucien Noens, Marie-Anne van Lierde, Robrecht De Bock, et al.
Clinical Hematology International|October 13, 2022
Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) StudyAnn Janssens, Zwi N Berneman, Fritz Offner, et al.
Acta Haematologica|June 5, 2019
Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in BelgiumTimothy Devos, Gregor Verhoef, Eva Steel, et al.
Annals of Hematology|June 25, 2020
COVID-19, impact on myeloma patientsInès Dufour, Juliette Raedemaeker, Fabio Andreozzi, et al.
Annals of Medicine|June 18, 2013
Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physiciansJo Caers, Marie-Christiane Vekemans, Greet Bries, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Annals of Hematology|February 15, 2011
Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromesMichel Delforge, Dominik Selleslag, Agnès Triffet, et al.
Haematologica|June 10, 2017
Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modificationsEmerence Crompot, Michael Van Damme, Karlien Pieters, et al.
Plos One|May 16, 2015
Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative controlEmerence Crompot, Michael Van Damme, Hugues Duvillier, et al.
European Journal of Haematology|December 30, 2017
Disease and treatment characteristics of polycythemia vera patients in Belgium: Results from a scientific surveyTimothy Devos, Yves Beguin, Lucien Noens, et al.
Haematologica|November 8, 2011
AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatmentsBasile Stamatopoulos, Nathalie Meuleman, Cécile De Bruyn, et al.
Blood|April 8, 2009
Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO studyLucien Noens, Marie-Anne van Lierde, Robrecht De Bock, et al.
Clinical Hematology International|October 13, 2022
Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) StudyAnn Janssens, Zwi N Berneman, Fritz Offner, et al.
Acta Haematologica|June 5, 2019
Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in BelgiumTimothy Devos, Gregor Verhoef, Eva Steel, et al.
Annals of Hematology|June 25, 2020
COVID-19, impact on myeloma patientsInès Dufour, Juliette Raedemaeker, Fabio Andreozzi, et al.
Annals of Medicine|June 18, 2013
Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physiciansJo Caers, Marie-Christiane Vekemans, Greet Bries, et al.
Pageof 3